111 results
Page 5 of 6
6-K
EX-99.1
8batvyp6cgv4ts
7 Aug 14
Teva Comments on Receipt of First Paragraph IV Notice for COPAXONE® 40 mg/mL (glatiramer acetate injection) Formulation
12:00am
6-K
EX-99.1
eh91fs hf
21 Jul 14
Live Filing
12:00am
6-K
EX-99.1
ndd3nyld
14 Jul 14
First Breath-Actuated Dry-Powder SABA Inhaler to be Accepted by FDA for Review
12:00am
6-K
EX-99.1
37uu8vwg52jb5xw0 mr
3 Jul 14
Current report (foreign)
12:00am
6-K
EX-99.1
fjsqp0 dmt61anqy72
20 Jun 14
Teva Reaches Settlement In Proair®hfa Patent Case
12:00am
6-K
EX-99.1
7u8451atg7
17 Jun 14
Teva Reaches Settlements In Nuvigil® Patent Case
12:00am
6-K
EX-99.1
2i6zz0
12 Jun 14
Teva Announces U.s. Court of Appeals Upholds Ruling Confirming Invalidity of Baraclude® Patent
12:00am
6-K
EX-99.1
u74a6y3m
9 Jun 14
FDA Approves Expanded Label for AZILECT® for Treatment Across All Stages of Parkinson’s Disease
12:00am
6-K
EX-99.1
v2i2genllk1lu8wxn6e
3 Jun 14
Live Filing
12:00am
6-K
EX-99.1
ieiytm k1
2 Jun 14
Appoints Sigurdur Olafsson As President and Ceo of Newly Established Global Generic Medicines Group
12:00am
6-K
EX-99.1
vx8 01sviya1qluh532
30 May 14
Teva Receives Favorable Court Decision Regarding Generic Celebrex ® Capsules; Teva should receive sole exclusivity for generic Celebrex ® Capsules
12:00am
6-K
EX-99.1
7ok8zflfi
27 May 14
Teva Announces Favorable European Patent Office Ruling In COPAXONE® Patent Proceeding
12:00am
6-K
EX-99.1
gj2wja037 70
23 May 14
Teva Received FDA Approval for QVAR® (beclomethasone dipropionate HFA) with Dose Counter
12:00am
6-K
EX-99.1
bu8s9l9mw1pu2yf
29 Apr 14
Teva Receives European Marketing Authorization for DuoResp Spiromax® for the Treatment of Asthma and COPD
12:00am
6-K
EX-99.1
he2u3muzv ksi2oypb46
28 Apr 14
Teva and Takeda Agree to Commercialize Rasagiline for Parkinson’s Disease Treatment In Japan
12:00am
6-K
EX-99.1
tzml45 rp4qq
28 Apr 14
Live Filing
12:00am
6-K
EX-99.1
rjt35cgog13grht22
24 Apr 14
Pride-hd Study Enrolling Patients Globally to Further Evaluate Pridopidine for the Symptomatic Treatment of Huntington’s Disease
12:00am
6-K
EX-99.1
tqoa9jwzoc8jhcby761
21 Apr 14
Live Filing
12:00am
6-K
EX-99.1
ys73346tij
15 Apr 14
Teva Announces Launch of Generic Lunesta® Tablets In the United States
12:00am
6-K
EX-99.1
dgjlh07r2y
8 Apr 14
Teva Announces First Approval and Launch of Generic Lovaza®capsules In the United States
12:00am